000 | 01083 a2200277 4500 | ||
---|---|---|---|
005 | 20250516060913.0 | ||
264 | 0 | _c20140815 | |
008 | 201408s 0 0 eng d | ||
022 | _a1872-7654 | ||
024 | 7 |
_a10.1016/j.ejogrb.2011.09.026 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGallos, Ioannis D | |
245 | 0 | 0 |
_aComment on: What about the relapse of endometrial hyperplasia? _h[electronic resource] |
260 |
_bEuropean journal of obstetrics, gynecology, and reproductive biology _cDec 2013 |
||
300 |
_ae5 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aAnticarcinogenic Agents _xadministration & dosage |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 |
_aEndometrial Hyperplasia _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevonorgestrel _xadministration & dosage |
700 | 1 | _aGupta, Janesh K | |
773 | 0 |
_tEuropean journal of obstetrics, gynecology, and reproductive biology _gvol. 171 _gno. 2 _gp. e5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejogrb.2011.09.026 _zAvailable from publisher's website |
999 |
_c21225997 _d21225997 |